Medicines Co. cardiovascular news

The Medicines Co. filed suit in the U.S. District Court for the Eastern District of Virginia against the U.S. Patent and Trademark Office, FDA and HHS seeking to set aside the PTO's March 19 denial of company's application to extend the term of a patent for anticoagulant Angiomax bivalirudin. Medicines Co. is asking the Court to instruct the PTO to accept the company's patent term extension application as timely and extend the term of the patent. ...